Skip to main content
Year archive

DR REDDYS LABORATORIES LTD — 2023 filings

All 273 regulatory filings released by DR REDDYS LABORATORIES LTD (RDY) in 2023, sourced directly from the official regulator.

273 Filings
2023 Period
2023 filings (273)
Filing Released Lang
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-12-31 English
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-12-30 English
Loss of share certificate(s)
Regulatory Filings
2023-12-29 English
FORM 6-K
Foreign Filer Report
2023-12-29 English
Appointment of Mr. Sanjiv Mehta as an Additional Director, categorized as Independent, on the Board of the Company.
Regulatory Filings
2023-12-29 English
Acquisition of securities by a wholly-owned step-down subsidiary company
Regulatory Filings
2023-12-29 English
6-K Filing
Foreign Filer Report
2023-12-29 English
Copies of newspaper publication
Regulatory Filings
2023-12-23 English
Loss of share certificate intimation
Regulatory Filings
2023-12-22 English
FORM 6-K
Foreign Filer Report
2023-12-21 English
Closure of Trading Window
Regulatory Filings
2023-12-21 English
DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2024 ,inter alia, to consider and approve The unaudited financial ....
Regulatory Filings
2023-12-21 English
FORM 6-K
Foreign Filer Report
2023-12-15 English
Press Release
Regulatory Filings
2023-12-14 English
FORM 6-K
Foreign Filer Report
2023-12-12 English
Clarification on reported news article
Regulatory Filings
2023-12-12 English
FORM 6K
Foreign Filer Report
2023-12-11 English
Issuance of Letter of confirmation in lieu of share certificate(s) lost/misplaced
Regulatory Filings
2023-12-11 English
Allotment of employee stock options
Regulatory Filings
2023-12-09 English
FORM 6-K
Foreign Filer Report
2023-12-08 English
Loss of share certificate(s)
Regulatory Filings
2023-12-08 English
Intimation regarding completion of USFDA inspection
Regulatory Filings
2023-12-08 English
The Exchange had sought clarification from Dr Reddys Laboratories Ltd with respect to news article appearing on https://www.business-standard.com dated December 05, 2023 (Link: https://www.business-st
Regulatory Filings
2023-12-07 English
FORM 6-K
Foreign Filer Report
2023-12-06 English
Press Release
Regulatory Filings
2023-12-06 English
FORM 6-K
Foreign Filer Report
2023-12-01 English
Schedule of Analyst / Institutional Investor Meetings
Regulatory Filings
2023-12-01 English
FORM 6-K
Foreign Filer Report
2023-11-28 English
Analyst/Investor Meet on 04/12/2023 - 05/12/2023
Regulatory Filings
2023-11-28 English
Copy of newspaper publication
Regulatory Filings
2023-11-24 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
Regulatory Filings
2023-11-23 English
FORM 6-K
Foreign Filer Report
2023-11-21 English
Allotment of shares under ESOP/ ESPS
Regulatory Filings
2023-11-21 English
FORM 6-K
Foreign Filer Report
2023-11-20 English
Analyst/Investor Meet
Regulatory Filings
2023-11-20 English
FORM 6-K
Foreign Filer Report
2023-11-17 English
Analyst/Investor Meet
Regulatory Filings
2023-11-17 English
FORM 6-K
Foreign Filer Report
2023-11-16 English
FORM 6-K
Foreign Filer Report
2023-11-16 English
Results of voting through Postal Ballot and Scrutinizer''s report
Regulatory Filings
2023-11-16 English
Press Release/Media release
Regulatory Filings
2023-11-16 English
FORM 6-K
Foreign Filer Report
2023-11-13 English
Acquisition of securities of O2 Renewable Energy IX Private Limited
Regulatory Filings
2023-11-10 English
FORM 6-K
Foreign Filer Report
2023-11-09 English
Intimation under Regulation 30 of the SEBI (Listing Obligations and Dislcosure Requirements) Regulations, 2015
Regulatory Filings
2023-11-09 English
FORM 6-K
Foreign Filer Report
2023-11-07 English
Loss of share certificates
Regulatory Filings
2023-11-07 English
Allotment of Equity shares on exercise of stock options under Employee stock options scheme
Regulatory Filings
2023-11-07 English
Intimation on filing of Form 6-K for the quarter ended September 30, 2023
Regulatory Filings
2023-11-02 English
Transcript of the earnings call conducted on October 27, 2023
Regulatory Filings
2023-11-01 English
FORM 6-K
Foreign Filer Report
2023-10-30 English
Copy of newspaper publication
Regulatory Filings
2023-10-28 English
Audio Recordings of the Earnings call conducted on October 27, 2023
Regulatory Filings
2023-10-28 English
Audio Recordings of the Earnings call conducted on October 27, 2023
Regulatory Filings
2023-10-28 English
FORM 6-K
Foreign Filer Report
2023-10-28 English
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-10-28 English
FORM 6-K
Foreign Filer Report
2023-10-27 English
Regulatory Filings 2023
Regulatory Filings
2023-10-27 English
Press Release
Regulatory Filings
2023-10-27 English
Unaudited Financial results for the quarter and half-year ended September 30, 2023
Regulatory Filings
2023-10-27 English
Outcome of Board Meeting - Unaudited Financial Results for the quarter and half-year ended September 30, 2023
Regulatory Filings
2023-10-27 English
FORM 6-K
Foreign Filer Report
2023-10-26 English
Grant of Employee Stock options
Regulatory Filings
2023-10-26 English
Postal Ballot Notice-Advertisement
Regulatory Filings
2023-10-18 English
FORM 6-K
Foreign Filer Report
2023-10-16 English
FORM 6-K
Foreign Filer Report
2023-10-16 English
Submission of Postal Ballot Notice
Regulatory Filings
2023-10-16 English
Earnings call notification for Q2 FY 2024
Regulatory Filings
2023-10-16 English
FORM 6-K
Foreign Filer Report
2023-10-12 English
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015
Regulatory Filings
2023-10-12 English
Loss of share certificate(s)
Regulatory Filings
2023-10-11 English
FORM 6-K
Foreign Filer Report
2023-10-10 English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-10-09 English
Compliance Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-10-06 English
Issuance of Letter of confirmation in lieu of share certificate(s)
Regulatory Filings
2023-10-05 English
FORM 6-K
Foreign Filer Report
2023-09-28 English
FORM 6-K
Foreign Filer Report
2023-09-28 English
Incorporation of step down wholly-owned subsidiary.
Regulatory Filings
2023-09-28 English
Disclosure pursuant to Regulation 30 of SEBI LODR Regulations
Regulatory Filings
2023-09-28 English
Intimation of Loss of Share certificate
Regulatory Filings
2023-09-26 English
FORM 6-K
Foreign Filer Report
2023-09-22 English
DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 ,inter alia, to consider and approve The Unaudited Financial ....
Regulatory Filings
2023-09-22 English
Issue of Letter of confirmation in lieu of share certificate(s) reported lost/misplaced
Regulatory Filings
2023-09-20 English
FORM 6-K
Foreign Filer Report
2023-09-19 English
FORM 6-K
Foreign Filer Report
2023-09-19 English
Appointment of Dr. Alpna Hansraj Seth as an Additional Director, categorized as Independent, on the Board of the Company.
Regulatory Filings
2023-09-19 English
Issue of Letter of confirmation in lieu of issuance of Duplicate share certificate(s)
Regulatory Filings
2023-09-19 English
Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Dislcosure Requirements) Regulations, 2015
Regulatory Filings
2023-09-19 English
FORM 6K
Foreign Filer Report
2023-09-18 English
Clarification/ information on reported news item
Regulatory Filings
2023-09-16 English
Newspaper publication
Regulatory Filings
2023-09-14 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
Regulatory Filings
2023-09-12 English
FORM 6K
Foreign Filer Report
2023-09-07 English
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst / Institutional Investor Meetings
Regulatory Filings
2023-09-07 English
FORM 6-K
Foreign Filer Report
2023-09-06 English
FORM 6-K
Foreign Filer Report
2023-09-06 English
Allotment of shares under ESOPs
Regulatory Filings
2023-09-05 English
Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015-information on reported news item
Regulatory Filings
2023-09-05 English
Loss of share certificate
Regulatory Filings
2023-09-01 English
Loss of Share certificates
Regulatory Filings
2023-08-30 English
FORM 6-K
Foreign Filer Report
2023-08-29 English
Cancellation of Certificate of Registration ("CoR") by RBI of M/s Imperial Credit Private Limited ("Wholly Owned Subsidiary")
Regulatory Filings
2023-08-29 English
Copy of newspaper publication-Loss of share certificate
Regulatory Filings
2023-08-29 English
FORM 6-K
Foreign Filer Report
2023-08-25 English
Announcement of equity shares on exercise of stock options.
Regulatory Filings
2023-08-24 English
FORM 6-K
Foreign Filer Report
2023-08-24 English
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst / Institutional Investor Meetings.
Regulatory Filings
2023-08-24 English
Loss of share certificate(s)
Regulatory Filings
2023-08-17 English
FORM 6-K
Foreign Filer Report
2023-08-16 English
Disclosure pursuant to Regulation 30 of SEBI LODR Regulations, 2015
Regulatory Filings
2023-08-14 English
FORM 6-K
Foreign Filer Report
2023-08-11 English
Press release
Regulatory Filings
2023-08-10 English
FORM 6-K
Foreign Filer Report
2023-08-08 English
Schedule of Analyst / Institutional Investor Meetings on 11.08.2023 and 21.08.2023
Regulatory Filings
2023-08-08 English
6-K Filing
Foreign Filer Report
2023-08-07 English
FORM 6-K
Foreign Filer Report
2023-08-04 English
Intimation
Regulatory Filings
2023-08-04 English
Details of Loss of share certificate(s)
Regulatory Filings
2023-08-04 English
Details of Loss of Share certificate(s)
Regulatory Filings
2023-08-04 English
Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-08-03 English
Announcement under Regulation 30 of SEBI LODR Regulations
Regulatory Filings
2023-08-02 English
FORM 6-K
Foreign Filer Report
2023-08-01 English
Transcript of Earnings call for Q1 FY24
Regulatory Filings
2023-07-31 English
FORM 6-K
Foreign Filer Report
2023-07-28 English
FORM 6-K
Foreign Filer Report
2023-07-28 English
Outcome of 39th AGM- scrutinizer''s report
Regulatory Filings
2023-07-28 English
Outcome of 39th AGM
Regulatory Filings
2023-07-28 English
Loss of share certificate
Regulatory Filings
2023-07-28 English
Regulatory Filings 2023
Regulatory Filings
2023-07-27 English
Intimation about filing of Form 6k for quarter ended June 30, 2023.
Regulatory Filings
2023-07-27 English
Newspaper publication for Q1 FY24 unaudited financial results
Regulatory Filings
2023-07-27 English
FORM 6-K
Foreign Filer Report
2023-07-27 English
FORM 6-K
Foreign Filer Report
2023-07-27 English
FORM 6-K
Foreign Filer Report
2023-07-27 English
FORM 6-K
Foreign Filer Report
2023-07-26 English
Intimation regarding Earnings call recording
Regulatory Filings
2023-07-26 English
Issue of Letter of Confirmation/Duplicate Share certificate
Regulatory Filings
2023-07-26 English
Retirement of Mr. Sridar Iyengar (DIN:00278512), Independent Director of the Company
Regulatory Filings
2023-07-26 English
Results-Press Release
Regulatory Filings
2023-07-26 English
Unaudited Financial results for quarter ended June 30, 2023
Regulatory Filings
2023-07-26 English
Announcement under Regulation 30 of the SEBI (Listing Obligations and Disclosure requirements) Regulations, 2015 (SEBI Listing Regulations)
Regulatory Filings
2023-07-26 English
Outcome of Board Meeting - Unaudited Financial Results for the quarter ended June 30, 2023
Regulatory Filings
2023-07-26 English
Allotment of Equity shares on exercise of stock options under ESOPs
Regulatory Filings
2023-07-25 English
FORM 6-K
Foreign Filer Report
2023-07-21 English
Updates on acquisition
Regulatory Filings
2023-07-20 English
Intimation regarding completion of USFDA inspection
Regulatory Filings
2023-07-19 English
6-K Filing
Foreign Filer Report
2023-07-19 English
FORM 6-K
Foreign Filer Report
2023-07-18 English
Earnings call notification for Q1 FY24
Regulatory Filings
2023-07-17 English
FORM 6-K
Foreign Filer Report
2023-07-17 English
The Company has entered into a security subscription and shareholders'' agreement for consumption and supply of renewable energy with TEQ Green Power XI Private Limited and O2 Power SG ....
Regulatory Filings
2023-07-15 English
FORM 6-K
Foreign Filer Report
2023-07-12 English
Dr. Reddy''s proposed rituximab biosimilar application accepted for review by USFDA, EMA and MHRA
Regulatory Filings
2023-07-12 English
FORM 6-K
Foreign Filer Report
2023-07-06 English
Copy of newspaper publication for notice of AGM and evoting instructions
Regulatory Filings
2023-07-05 English
Copy of newspaper publication-Duplicate share certificate
Regulatory Filings
2023-07-04 English
Loss of share certiifcate(s)
Regulatory Filings
2023-07-04 English
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Regulatory Filings
2023-07-03 English
6-K Filing
Foreign Filer Report
2023-07-03 English
Integrated Annual Report FY23 and Notice of 39th AGM
Regulatory Filings
2023-07-01 English
BRSR for FY23
Regulatory Filings
2023-07-01 English
Intimation regarding despatch of Notice of 39th AGM and Integrated Annual Report FY2023.
Regulatory Filings
2023-07-01 English
FORM 6-K
Foreign Filer Report
2023-06-23 English
FORM 6-K
Foreign Filer Report
2023-06-23 English
Press Release on ''Dr. Reddy's enters the trade generics business in India''
Regulatory Filings
2023-06-23 English
Allotment of Equity Shares on exercise of Stock Options under ESOPs
Regulatory Filings
2023-06-22 English
The trading window for dealing in securities of the Company will be closed from June 24, 2023, to July 28, 2023 (both days inclusive).
Regulatory Filings
2023-06-21 English
DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2023 ,inter alia, to consider and approve Consideration and ....
Regulatory Filings
2023-06-21 English
FORM 6-K
Foreign Filer Report
2023-06-20 English
FORM 6K
Foreign Filer Report
2023-06-20 English
Newspaper ad for TDS communication on dividend payout
Regulatory Filings
2023-06-19 English
Intimation regarding: a) completion of GMP inspection by USFDA of our API facility at Bollaram (CTO3) with zero observations and b) receipt of EIR for closure of the USFDA inspection ....
Regulatory Filings
2023-06-16 English
Intimation of Loss of Share certificate(s)
Regulatory Filings
2023-06-16 English
FORM 6-K
Foreign Filer Report
2023-06-14 English
Dr. Reddy's Laboratories Limited announces filing of Annual Report on Form 20-F
Regulatory Filings
2023-06-14 English
FORM 20-F
Annual Report FY 2023
2023-06-13 English
FORM 6-K
Foreign Filer Report
2023-06-13 English
Schedule of Analyst / Institutional Investor Meetings
Regulatory Filings
2023-06-12 English
Copy of Newspaper Publication regarding transfer of unclaimed dividend and underlying equity shares to Investor Education and Protection Fund (IEPF)
Regulatory Filings
2023-06-08 English
FORM 6-K
Foreign Filer Report
2023-06-05 English
Dr. Reddy's successfully completes Phase I study (IV route) of DRL_TC, a proposed biosimilar of tocilizumab
Regulatory Filings
2023-06-05 English
Allotment of Equity Shares on exercise of Stock Options under ESOPs
Regulatory Filings
2023-06-03 English
FORM 6-K
Foreign Filer Report
2023-06-01 English
Intimation regarding institutional investor meetings
Regulatory Filings
2023-05-31 English
Annual Secretarial Compliance Report for the year ended March 31, 2023
Regulatory Filings
2023-05-26 English
Loss of Share Certificates
Regulatory Filings
2023-05-25 English
FORM 6-K
Foreign Filer Report
2023-05-22 English
Intimation about Investor conference participation
Regulatory Filings
2023-05-22 English
Loss of Share certificate
Regulatory Filings
2023-05-19 English
FORM 6-K
Foreign Filer Report
2023-05-16 English
Transcript of the Earnings call conducted on May 10, 2023
Regulatory Filings
2023-05-15 English
FORM 6-K
Foreign Filer Report
2023-05-15 English
Intimation regarding completion of US FDA audit of FTO SEZ PU2.
Regulatory Filings
2023-05-12 English
Intimation regarding completion of US FDA audit of FTO SEZ PU2.
Regulatory Filings
2023-05-12 English
FORM 6-K
Foreign Filer Report
2023-05-12 English
Copies of newspaper advertisement regarding audited financial results for the quarter and year ended March 31, 2023
Regulatory Filings
2023-05-11 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the link of the audio recording ....
Regulatory Filings
2023-05-11 English
FORM 6-K
Foreign Filer Report
2023-05-10 English
FORM 6-K
Foreign Filer Report
2023-05-10 English
Pursuant to Regulation 23(9) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the applicable disclosure on ....
Regulatory Filings
2023-05-10 English
39th Annual General Meeting (AGM) of the members of the Company scheduled to be held on Thursday, July 27, 2023. The Register of Members and the Share Transfer Books of the Company shall ....
Regulatory Filings
2023-05-10 English
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regulatory Filings
2023-05-10 English
Audited Financial Results for FY23
Regulatory Filings
2023-05-10 English
Press Release - Audited Financial Results of FY23
Regulatory Filings
2023-05-10 English
Recommendation of final dividend for the financial year 2022-23.
Regulatory Filings
2023-05-10 English
Outcome of Board Meeting held on May 10, 2023 - Audited Financial Results and recommendation of Dividend for FY23
Regulatory Filings
2023-05-10 English
Grant of employee stock options
Regulatory Filings
2023-05-09 English
FORM 6-K
Foreign Filer Report
2023-05-05 English
Intimation about USFDA audit at our CTO 1 unit at Bollaram
Regulatory Filings
2023-05-05 English
Press release on Dr. Reddy''s Laboratories announces the launch of Regadenoson Injection 0.4 mg/5 mL in the U.S.
Regulatory Filings
2023-05-05 English
Press release on Dr. Reddy''s Laboratories announces the launch of Regadenoson Injection 0.4 mg/5 mL in the U.S.
Regulatory Filings
2023-05-05 English
Loss of Share Certificates
Regulatory Filings
2023-04-28 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2023-04-28 English
FORM 6-K
Foreign Filer Report
2023-04-24 English
Earnings call intimation Q4 FY23
Regulatory Filings
2023-04-22 English
FORM 6-K
Foreign Filer Report
2023-04-21 English
Dr. Reddy''s Laboratories announces the launch of Treprostinil Injection in the U.S.
Regulatory Filings
2023-04-21 English
Certificate under Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended March 31, 2023
Regulatory Filings
2023-04-20 English
Loss of share certificate
Regulatory Filings
2023-04-19 English
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-04-17 English
Issue of Letter of Confirmation in lieu of share certificate(s) reported lost/misplaced
Regulatory Filings
2023-04-11 English
Compliance certificate pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-04-08 English
FORM 6-K
Foreign Filer Report
2023-04-07 English
Update on Press Release dated February 27, 2023 regarding completion of transaction
Regulatory Filings
2023-04-07 English
FORM 6-K
Foreign Filer Report
2023-03-24 English
FORM 6-K
Foreign Filer Report
2023-03-24 English
Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-03-23 English
The trading window for dealing in securities of the Company will be closed from March 25, 2023, to May 12, 2023 (both days inclusive).
Regulatory Filings
2023-03-23 English
DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2023 ,inter alia, to consider and approve Audited Standalone ....
Regulatory Filings
2023-03-23 English
FORM 6-K
Foreign Filer Report
2023-03-21 English
Allotment of Equity Shares on exercise of Stock Options under ESOPs
Regulatory Filings
2023-03-21 English
Loss of Share Certificates
Regulatory Filings
2023-03-17 English
FORM 6-K
Foreign Filer Report
2023-03-16 English
Dr. Reddy's divests certain non-core brands in dermatology in India to Eris Lifesciences to focus on strengthening core
Regulatory Filings
2023-03-16 English
FORM 6-K
Foreign Filer Report
2023-03-13 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
Regulatory Filings
2023-03-13 English
Allotment of Equity Shares on exercise of Stock Options under ESOPs
Regulatory Filings
2023-03-12 English
FORM 6-K
Foreign Filer Report
2023-02-28 English
Intimation - Schedule of Analyst / Institutional Investor Meetings
Regulatory Filings
2023-02-28 English
FORM 6-K
Foreign Filer Report
2023-02-27 English
Dr. Reddy''s Laboratories announces agreement to acquire Mayne Pharma's U.S. generic prescription product portfolio
Regulatory Filings
2023-02-27 English
FORM 6-K
Foreign Filer Report
2023-02-17 English
Allotment of Equity Shares on exercise of Stock Options under ESOPs
Regulatory Filings
2023-02-16 English
FORM 6-K
Foreign Filer Report
2023-02-09 English
Dr. Reddy's included in Bloomberg Gender-Equality Index for the 6th year in a row and S&P Global's Sustainability Yearbook for the 3rd year
Regulatory Filings
2023-02-08 English
FORM 6-K
Foreign Filer Report
2023-02-03 English
Intimation regarding participation at Analyst/investor meet
Regulatory Filings
2023-02-03 English
FORM 6-K
Foreign Filer Report
2023-01-30 English
Intimation on Transcript of the Earnings call conducted on January 25, 2023
Regulatory Filings
2023-01-30 English
FORM 6-K
Foreign Filer Report
2023-01-27 English
Press Release on 'Dr. Reddy''s Laboratories announces the launch of Difluprednate Ophthalmic Emulsion 0.05% in the U.S. Market'.
Regulatory Filings
2023-01-27 English
FORM 6-K
Foreign Filer Report
2023-01-27 English
Copies of Newspaper advertisement for the unaudited financial results for quarter and nine months ended December 31, 2022
Regulatory Filings
2023-01-26 English
FORM 6-K
Foreign Filer Report
2023-01-26 English
Intimation regarding filing of Form 6-K for the quarter ended December 31, 2022, filed with United States Securities and Exchange Commission.
Regulatory Filings
2023-01-26 English
Audio Recording of the Earnings call conducted on January 25, 2023
Regulatory Filings
2023-01-26 English
FORM 6-K
Foreign Filer Report
2023-01-25 English
FORM 6-K
Foreign Filer Report
2023-01-25 English
Issue of Letter of Confirmation in lieu of share certificate(s) reported lost/misplaced
Regulatory Filings
2023-01-25 English
Unaudited Financial Results for the quarter and nine months ended December 31, 2022
Regulatory Filings
2023-01-25 English
Outcome of Board Meeting - Unaudited Financial Results for the quarter and nine months ended December 31, 2022
Regulatory Filings
2023-01-25 English
Intimation regarding grant of 3234 stock options to eligible employees
Regulatory Filings
2023-01-25 English
6-K Filing
Foreign Filer Report
2023-01-25 English
FORM 6-K
Foreign Filer Report
2023-01-20 English
Press Release on "Dr. Reddy's successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe"
Regulatory Filings
2023-01-20 English
Compliance certificate under Reg 74(5) of the SEBI (DP) Regulations
Regulatory Filings
2023-01-14 English
FORM 6-K
Foreign Filer Report
2023-01-13 English
Dr. Reddy's launches in-house palbociclib (PRIMCYV®) to widen access to high-quality breast cancer drug
Regulatory Filings
2023-01-13 English
FORM 6-K
Foreign Filer Report
2023-01-13 English
Dr. Reddy''s to release Q3 FY 23 results on January 25th, 2023 Earnings call slated for January 25th @ 7:00 PM IST / 8:30 AM EST
Regulatory Filings
2023-01-12 English
Intimation regarding resignation of Mr. Allan Oberman as an Independent Director
Regulatory Filings
2023-01-06 English
Intimation regarding participation at investor conferences
Regulatory Filings
2023-01-06 English
6-K Filing
Foreign Filer Report
2023-01-06 English